Patent holdings for IPC class C07J 63/00

Total number of patents in this class: 487

10-year publication summary

29
26
53
36
33
43
32
35
33
7
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

Principal owners for this class

Owner
All patents
This class
Reata Pharmaceuticals, Inc.
127
37
Reata Pharmaceuticals Holdings, LLC
42
18
Sage Therapeutics, Inc.
312
15
ViiV Healthcare UK (no.5) Limited
86
13
Hetero Labs Limited
46
13
Shanghai Institute of Materia Medica, Chinese Academy of Sciences
762
12
Bristol-myers Squibb Company
5080
9
Glaxosmithkline LLC
566
7
Ardelyx, Inc.
109
7
Pacific Arrow Limited
19
7
Glaxosmithkline Biologicals S.A.
1701
6
Adjuvance Technologies, Inc., AKA Adjuvance
21
6
Daiichi Sankyo Company, Limited
1829
6
Regents of the University of Minnesota
2620
6
ViiV Healthcare UK (No. 4) Limited
25
6
ViiV Healthcare UK (No. 5) Limited
42
6
Glaxosmithkline Intellectual Property (no.2) Limited
269
5
Memorial Sloan-Kettering Cancer Center
1789
5
Valtion Teknillinen Tutkimuskeskus
183
5
The General Hospital Corporation
4517
4
Other owners 294